About Us
Eurofins ADME BIOANALYSES: a Contract Research Organisation
Eurofins ADME BIOANALYSES is a Contract Research Organisation providing diverse services to the pharmaceutical industry in the fields of pharmacokinetics and drug metabolism.
Based at our site in the heart of Southern France we have over 2500m2 of laboratory and office space with a team of 100 FTE.
We have four business units which, working cooperatively between each other and in partnership with other Eurofins entities, can offer the full range of pre-clinical and clinical DMPK services.
- Small molecule bioanalysis
- Large molecule bioanalysis
- Biomarkers
- Dermal absorption and in vivo studies
Through regular, ongoing investments in equipment and staff training we target the optimisation of our client's registration timelines in the pharmaceutical, cosmetic or nutrition industries.
Eurofins ADME BIOANALYSES: history
Eurofins ADME BIOANALYSES was founded originally as ADME BIOANALYSES in 1987 in Sophia Antipolis (near Nice) in France by Dr. Patrick Duchêne.
In 1999, the Company moved to new facilities in Vergèze, between Montpellier and Nîmes in France.
In 2005, the Company joined the Eurofins Scientific Group to expand its technological and geographical reach. This new organisation allowed the Company to strengthen its market position and to accelerate its development to provide ever increasing quality and range of technical services.
In 2013 and 2017, the Company increased its capacities with two consecutive extensions at the Vergèze site.
In 2018, following the retirement of the company founder, Dr. Tanja Schubert became the company CEO.
Eurofins ADME BIOANALYSES’ primary objective is to keep increasing its capacities and range of service offerings whilst remaining a gold standard partner for its clients.
